At Translucent, we recognise the importance of puberty blockers in healthcare options available to young people under 18 who are transgender. As part of this, we’ve written articles concerning puberty blockers in order to:
This letter critiques the UK government’s trans healthcare policies, which are based on gender critical ideology from the Cass and Sullivan Reviews, and warns of human rights violations and potential genocide as highlighted by the Lemkin Institute. Continue Reading Letter to Dame Gillian Merron – Challenging UK Trans Healthcare Policy
The Lemkin Institute has issued a “Red Alert for Genocide” for the UK trans and intersex community due to concerning governmental and judicial actions. Continue Reading Genocide Warning Issued for UK Trans Community
A new research paper reveals severe adverse effects including declining mental health, increased depression, self-harm, and suicide ideation among trans and non-binary young people and their parents following the UK puberty blocker ban Continue Reading The UK Puberty Blocker Ban: Evidence Reveals Widespread Harm to Transgender Children
Sullivan Report Editorial Criticism: The Observer faces criticism for its editorial on the Sullivan Report which promoted gender-critical views, leading a reader to cancel their subscription, while TransLucent is also critical. Continue Reading Open Letter to The Observer re Sullivan Report
The NHS’s puberty-blockers trial is a danger to children – a response” argues that the evidence base for puberty blockers is scientific, not ideological, and criticises the gender-critical movement for manipulating science and being linked to anti-LGBT hate groups. Continue Reading The NHS puberty-blockers trial is a danger to children – a response
The Cass Report is controversial because many organisations have criticised it, contrasting it with the more transparent Swiss Report which contradicts Cass in its approach to treatment, evidence, and data interpretation. Continue Reading The Cass Report Scandal
The Cass Review briefing note examines the Cass Review’s recommendations for gender identity services. TransLucent’s report identifies concerns from service users, professionals, and human rights organisations, and offers solutions. Continue Reading The Cass Review – Briefing Note
A Fifty-fold Increase in the number of Children suffering from Gender Dysphoria reported in the media. On the 24th of…
The Cass Review was politically motivated and not transparent, and it was criticised by health professionals worldwide. Continue Reading Are politicians trying to undermine the Cass Review – A Response
Misinformation about transgender healthcare, often originating from US-based organisations, is being spread globally, targeting gender-affirming healthcare, and puberty blockers. This misinformation relies on false claims about the risks of puberty blockers, the alleged widespread regret of transitioning individuals (contradicted by a 95%-98% satisfaction rate), and the unfounded concept of Rapid Onset Gender Dysphoria (ROGD) purported to be a social contagion. Continue Reading Transgender Health – Misinformation
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.